Budget update includes impact of listings, but generally not much else

The half-yearly update tends to suggest higher spending on pharmaceuticals simply because of the impact of new listing decisions since May. However, it does not include published updated forecasts for pharmaceutical expenditures. It merely states the topline impact of listings since May. …